Skip to main content
    D

    DocGo Inc (DCGO)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $0.19
    -0.02 (-8.53%)

    Market Cap: $20.55M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    DocGo Inc (DCGO) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect DocGo (DCGO) to earn -$0.93 per share in the fiscal year ending Dec 31, 2026, on revenue of $299.39M. Of 5 analysts, 2 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 0 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 5 ratings average 2.40, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 40% of the ratings.

    RatingAnalystsShare
    Strong Buy120.0%
    Buy120.0%
    Hold360.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Buy
    Total analysts
    5

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus turns from a loss to a profit and revenue estimates rise 3.2%.

    Fiscal year ending Dec 31, 2026
    -$0.93
    EPS consensus, revenue $299.39M
    Fiscal year ending Dec 31, 2027
    $0.02
    EPS consensus, revenue $309.09M
    Next report
    Mar 15, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.93-$1.07 to -$0.802$299.39M$297.08M to $300.60M5
    Dec 31, 2027$0.02-$0.18 to $0.222$309.09M$289.00M to $322.68M5

    Quarterly Estimates

    The EPS consensus falls from -$0.07 for the quarter ending Dec 31, 2026 to -$0.29 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026-$0.07-$0.08 to -$0.067$79.17M$73.18M to $84.31M7
    Mar 31, 2027-$0.29-$0.37 to -$0.222$77.80M$73.91M to $80.64M3

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 1 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202601
    Fiscal year ending Dec 31, 202701
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has worsened from -$0.43.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026-$0.93-$0.79-$0.79-$0.79-$0.43N/A
    Fiscal year ending Dec 31, 2027$0.02$0.14$0.14$0.14$0.19-90.1%
    Quarter ending Mar 31, 2027-$0.29-$0.31-$0.31-$0.31-$0.33N/A

    Frequently Asked Questions About DCGO

    What is the DCGO stock forecast?

    Consensus analyst estimates put DocGo's EPS at -$0.93 for the fiscal year ending Dec 31, 2026, on revenue of $299.39M. The consensus rating from 5 analysts is Buy.

    How do analysts rate DCGO stock?

    Of 5 analysts covering DocGo, 1 rates it Strong Buy, 1 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.

    What EPS do analysts expect from DCGO next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.93, with estimates from -$1.07 to -$0.80 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $0.02, with estimates from -$0.18 to $0.22 from 2 analysts.

    What revenue do analysts expect from DocGo next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $299.39M, with estimates from $297.08M to $300.60M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $309.09M, with estimates from $289.00M to $322.68M.

    How many analysts cover DCGO?

    5 analysts rate DocGo stock, and 2 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.